GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Etrasimod - VELSIPITY tablets

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

An RX mirror and its underlying label are not independent clinical confirmations.

Check source scope before reading a dose

VELSIPITY: selected RX renal passage

Product / population
Adult oral VELSIPITY for labeled ulcerative colitis; renal PK finding only, not a complete prescribing checklist.
Renal method
eGFR <=29 mL/min as printed in selected PK text; indexing not specified there
Source revision
Revision date not established in reviewed mirror passage.
Retrieved
2026-11-07
Local review status
Selected sections checked against the identified source; not a complete monograph or independent clinician approval.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

VELSIPITY: source applicability and renal evidence limits

Selected passage does not establish dialysis dosing. The RX mirror is not independent corroboration of the matched label.

What to reconcile: Apply the full pretreatment and safety checklist, not this PK finding alone.

Selected-source comparison; independent clinician adjudication pending.

Open this note and its source references
Rxlist

VELSIPITY: selected RX renal passage

Open original reference

GlobalRPh RX List / label mirror · Adult oral VELSIPITY for labeled ulcerative colitis; renal PK finding only, not a complete prescribing checklist.

Renal method: eGFR <=29 mL/min as printed in selected PK text; indexing not specified there
Source date: Revision date not established in reviewed mirror passage.
Retrieved: 2026-11-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Pharmacokinetic observation only. A drug-exposure observation is not itself a dose recommendation.
Before using this finding

Selected passage does not establish dialysis dosing.

Dialysis evidence: No dialysis regimen established in selected content

Selected sections checked against the identified source; not a complete monograph or independent clinician approval.

Section 12.3, Specific Populations

The mirror reports no clinically significant PK difference in severe impairment, with eGFR <=29 mL/min as printed. It does not provide a dialysis schedule.

RDM72-etrasimod-velsipity-rx-1 · Source locator: Section 12.3, Specific Populations

Source-specific limits

Selected renal section, not a complete prescribing monograph. A label and its mirror are not independent evidence.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/velsipity-drug/
Retrieved
2026-11-07
Renal-function method
eGFR <=29 mL/min as printed in selected PK text; indexing not specified there
Source date/version
Revision date not established in reviewed mirror passage.
Hash meaning
Locally authored summary text; not original source HTML, XML or PDF bytes
Local summary SHA-256
5ca6869cd4bcf5903935633e1fb5d25d79297504f3cce5663e034f8ce3657a54

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=etrasimod-velsipity&s1=RDM72-etrasimod-velsipity-rx&h1=d33d8a312c0ecded91486f2a1244e6cf9aa288f43dcc23248045400f263e09d0

Top